SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-052417
Filing Date
2023-10-06
Accepted
2023-10-06 16:30:32
Documents
15
Period of Report
2023-10-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cmra-20231006.htm   iXBRL 8-K 77681
2 EX-10.1 cmra-ex10_1.htm EX-10.1 73620
3 GRAPHIC img190621547_0.jpg GRAPHIC 79071
  Complete submission text file 0000950170-23-052417.txt   436719

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmra-20231006_def.xml EX-101.DEF 14681
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmra-20231006.xsd EX-101.SCH 3387
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmra-20231006_pre.xml EX-101.PRE 14886
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmra-20231006_lab.xml EX-101.LAB 23251
9 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20231006_htm.xml XML 6429
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 231314562
SIC: 2834 Pharmaceutical Preparations